NCT01213862

Brief Summary

Home visits (HV) are one of the multidisciplinary approaches that has already shown to benefit the follow-up of Heart Failure (HF) patients. It is considered to be one of the most effective and humane approaches as it educates and takes care of the patient in his/her routine environment. In this study, the follow-up of HF patients in a home setting after being discharged from hospital will include the reinforcement, monitoring and re-evaluation of guidelines previously provided about the disease and self-care, compliance to prescribed medicines and, specially, the early recognition of decompensation signs and symptoms by patients and their caregivers.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Aug 2009

Typical duration for not_applicable heart-failure

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2009

Completed
11 months until next milestone

First Posted

Study publicly available on registry

October 4, 2010

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

January 3, 2014

Status Verified

December 1, 2013

Enrollment Period

3.4 years

First QC Date

November 9, 2009

Last Update Submit

December 31, 2013

Conditions

Keywords

Home Based educationKnowledge of DiseaseSelf-Care SkillsQuality of LifeHeart FailureRandomized Clinical Trial

Outcome Measures

Primary Outcomes (3)

  • Knowledge of the disease

    This primary outcome will be measured at each home visit, which will have different intervals, according to the research protocol.

    Home visit 7 days after discharge

  • Self-care skills.

    This primary outcome will be measured at each home visit, which will have different intervals, according to the research protocol.

    Home visit 7 days after discharge.

  • Quality of Life

    This primary outcome will be measured at each home visit, which will have different intervals, according to the research protocol.

    Home visit 7 days after discharge

Secondary Outcomes (3)

  • Changes in functional class.

    Home visits (HV) starting 7days after discharge.

  • Presentation to emergency department

    Home visits starting 7 days after discharge.

  • Compliance score.

    Home visits starting 7 days after discharge.

Study Arms (1)

intervention and control

EXPERIMENTAL

* Group I - Intervention: Routine follow-up in a reference health institution with four home visits and four telephone contacts with specialist nurses. * Group II - Control: Routine follow-up with the health team in the reference institution.

Behavioral: Home Based Education

Interventions

There will provided education about what is heart failure, its causes, how to recognize signs and symptoms, monitoring of weight and blood pressure, the importance of compliance to treatment. Patients will be instructed about the medications; a guide to rest and exercise, sexual activity, vaccines, travel and diet will be provided. The involvement of the family will be encouraged; the contact with the team should be done when: patient observes an increase of 1 or 2 kg of weight in 2-3 days, worsening of dyspnea on effort, edema in legs / abdomen, worsening of cough, persistent vomiting, syncope, sputum with blood, fever, persistent tachycardia. In phone calls made between home visits, the compliance to treatment will be evaluated and reinforced.

Also known as: Education on Heart Failure, Home based intervention
intervention and control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both sexes
  • Age equal to or above 18 years
  • Diagnosis of heart failure with systolic dysfunction (ejection fraction ≤ 45%)
  • Hospitalized for heart failure decompensation and who agree to participate in the study by signing a Free Informed Consent Form.

You may not qualify if:

  • Patients presenting with communication barriers and suffering from degenerative neurological diseases.
  • Patients who had Acute Coronary Syndrome (ACS) in the past 6 months before randomization
  • Patients with renal/hepatic/pulmonary or systemic disease who may confuse the interpretation of findings or result in limited life expectancy
  • Surgical or therapeutic treatment that may influence the follow-up
  • Pregnancy
  • Diagnosis of Heart Failure secondary to:
  • sepsis
  • myocarditis
  • acute myocardial infarction
  • peripartum cardiomyopathy and other acute cause
  • No interest in receiving home visits
  • Living more than 10 km away for the original hospital
  • No possibility of telephone contact.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Mussi CM, Ruschel K, de Souza EN, Lopes AN, Trojahn MM, Paraboni CC, Rabelo ER. Home visit improves knowledge, self-care and adhesion in heart failure: Randomized Clinical Trial HELEN-I. Rev Lat Am Enfermagem. 2013 Jan-Feb;21 Spec No:20-8. doi: 10.1590/s0104-11692013000700004. English, Portuguese.

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Eneida R Rabelo da Silva, RN, ScD

    Federal University of Rio Grande do Sul

    PRINCIPAL INVESTIGATOR
  • Eneida R Rabelo da Silva, RN, ScD

    Universidade Federal do Rio do Sul

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, PhD.

Study Record Dates

First Submitted

November 9, 2009

First Posted

October 4, 2010

Study Start

August 1, 2009

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

January 3, 2014

Record last verified: 2013-12